Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Int J Cancer. 2011 Jan 1;128(1):40–50. doi: 10.1002/ijc.25307

TABLE II.

Ndpk, histidine kinase and exonuclease activities of Nm23-H1 variants

Protein NDPK1 Histidine kinase2 Exonuclease3
WT 627 ± 36d    (100) 9.9    (100) 28.4 ± 4.0    (100)
E5A 438 ± 31c    (70) 8.2    (83) 3.4 ± 1.5*    (12)
K12Q 14 ± 0.9a     (2) 0.9     (9) 5.2 ± 3.5*    (18)
Q17N 516 ± 10c    (82) 6.5    (66) 31.4 ± 6.0    (110)
Y52A B.D.a 0.4     (4) 25.3 ± 3.9    (89)
P96S 127 ± 5b    (20) 1.1    (11) 24.9 ± 5.1    (88)
H118F B.D.4 B.D. 33.0 ± 9.0    (116)
1

NDPK activity is expressed in units/mg (mean ± S.E.), derived from at least three replicate measurements and three independent protein preparations. Activity expressed relative to wild-type is displayed in parentheses.

2

Histidine kinase activity is expressed as the percent of 32P radiolabeled NM23-H2 substrate converted to a phosphorylated per minute.

3

Exonuclease activity is expressed in fmol of 32P liberated from radiolabeled nucleotide substrate per 5 min (mean ± SE) as determined with three replicate measurements for at least three independent protein preparations.

4

B.D., below detection.

a–d

Means not bearing a common superscript are significantly different (p ≤ 0.01), as determined by one-way ANOVA and mean separation by Student’s t-Test.

*

Means bearing an asterisk within a column are significantly different (p ≤ 0.05), as determined by one-way ANOVA and mean separation by Student’s t-Test.